Innoveren Scientific Inc. (IVRN)
OTCMKTS: IVRN · Delayed Price · USD
0.0300
0.00 (0.00%)
Apr 16, 2024, 12:00 AM EDT - Market open

Innoveren Scientific Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20212020201920182017201620152014
Revenue
1.612.158.357.880.21000
Revenue Growth (YoY)
-25.07%-74.23%5.88%3701.95%----
Cost of Revenue
0.70.772.052.370.16000
Gross Profit
0.911.386.295.520.04000
Selling, General & Admin
4.917.3220.49.015.595.264.661.91
Research & Development
01.150.1100.491.130.871.02
Other Operating Expenses
1.28016.340.70.036.470.010
Operating Expenses
6.198.4836.859.716.1112.865.542.94
Operating Income
-5.29-7.09-30.56-4.19-6.06-12.86-5.54-2.94
Interest Expense / Income
0.181.460.30.180.40.460.050
Other Expense / Income
-0.66-2.1-1.050.02-6.462.910.94-
Pretax Income
-4.8-6.46-29.81-4.390-16.23-6.52-2.94
Net Income
-4.8-6.46-29.81-4.390-16.23-6.52-2.94
Preferred Dividends
00.323.3900000
Net Income Common
-4.8-6.78-33.2-4.390-16.23-6.52-2.94
Shares Outstanding (Basic)
00000000
Shares Outstanding (Diluted)
00000000
Shares Change
30.72%15.69%186.30%75.84%44.46%21.08%38.58%-
EPS (Basic)
-30.00-60.00-340.00-130.00-340.00-1220.00-600.00-370.00
EPS (Diluted)
-30.00-60.00-340.00-130.00-340.00-1220.00-600.00-370.00
Free Cash Flow
-4.82-7.26-12.31-3.56-5.61-5.51-5.99-2.78
Free Cash Flow Per Share
-33.06-65.12-127.76-105.64-292.91-416.02-547.26-352.48
Gross Margin
56.27%64.34%75.41%69.98%21.47%---
Operating Margin
-327.99%-329.77%-366.11%-53.18%-2923.13%---
Profit Margin
-297.81%-315.32%-397.71%-55.74%----
Free Cash Flow Margin
-298.95%-337.57%-147.50%-45.11%-2704.27%---
EBITDA
-4.61-4.92-28.67-4.110.42-15.57-6.04-2.93
EBITDA Margin
-285.86%-228.53%-343.53%-52.20%203.73%---
Depreciation & Amortization
0.020.080.830.10.030.20.430
EBIT
-4.62-5-29.51-4.210.4-15.77-6.48-2.94
EBIT Margin
-286.84%-232.32%-353.53%-53.40%190.66%---
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).